Renewal of Continuing Connected Transactions and Related Party Transaction and Entering into of Continuing Connected Transactions

Overseas Regulatory Announcement-Announcement on Having Obtained FDA approval of Abbreviated New Drug Application (ANDA)

Overseas regulatory announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Articles of Association

Poll Results of The Extraordinary General Meeting

Announcement Notice of Board Meeting

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2024

Reply Slip for the First Extraordinary General Meeting for the Year 2024

Proxy Form for the First Extraordinary General Meeting for the Year 2024

Notice of Extraordinary General Meeting